GRK2 and rheumatoid arthritis: Based on the findings, we hypothesize that in RA-FLSs, increased GRK2 results in PDE4D upregulation, reducing intracellular cAMP and exacerbating RA by promoting uncontrolled FLSs hyperproliferation.